P368 Antibiotic prescribing practice of the cystic fibrosis (CF) nursing team at a large tertiary paediatric centre

Non-medical prescribing is now an established role within the CF multidisciplinary team. It important to monitor practice and identify changing trends in line with antibiotic stewardship principles, addition evaluating service provision. Prospective data collection was completed over 2 months (Sept-Oct 2022) by 3 non-medical prescribers at a tertiary centre UK. Patient demographics, symptoms prescriptions were recorded analysed. 72 for antibiotics. 43 (60%) patients under age of 6, 20 (27%) those aged 6–11 years 9 (13%) over-12 s. 31/43 6 not on modulator therapy compared 6/29 years. Of modulators, 68% Kaftrio, 29% Orkambi 3% Ivacaftor. 52 (72%) co-amoxiclav, 7 (10%) flucloxacillin, (4%) anti-Pseudomonal 10 (14%) others (azithromycin or co-trimoxazole). Microbiology samples obtained 25 occasions (35%) prior commencing A similar proportion microbiology sampling seen across all three groups. 13% asymptomatic whom positive respiratory culture had been obtained. 77% acutely symptomatic children cough being most common symptom. 24 (33%) started antibiotics days symptom onset. 14 (19%) treatment after more symptoms, however. Antibiotic element nurse prescribing. The majority this younger patients. Relatively prescribed modulators. explore reasons early late Irrespective two thirds did have current sample inform choice prescription.